Dr. Schulz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UT Physicians Neurocognitive Disorders
1941 E Rd, Ste 4358
Houston, TX 77054Phone+1 713-486-0500Fax+1 713-383-1435
Summary
- Dr. Paul Schulz is a neurologist in Houston, TX and is affiliated with Memorial Hermann - Texas Medical Center. He received his medical degree from Boston University School of Medicine and has been in practice 33 years. He specializes in neurodegenerative and dementia & geriatrics and is experienced in amyotrophic lateral sclerosis, dementia, alzheimer's disease, risk management, and cognitive disorders.
Education & Training
- Baylor College of MedicineResidency, Neurology, 1985 - 1988
- Boston VA Healthcare System (Brockton-West Roxbury)Internship, Internal Medicine, 1984 - 1985
- Boston UniversityB.A., Medical Sciences and Psychology, Magna Cum Laude, 1977 - 1984
- Boston University School of MedicineClass of 1984
Certifications & Licensure
- TX State Medical License 1988 - 2026
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- “Dean’s Excellence in Teaching Award” UTHealth, 2022
- "Dean's Teaching Excellence Award" UTHealth, 2012
- "Doctor's Choice" Health and Fitness Magazine, 2009
- Join now to see all
Clinical Trials
- Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy Start of enrollment: 2015 Jul 01
- A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD). Start of enrollment: 2016 Mar 22
- A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease Start of enrollment: 2016 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 133 citationsGreater Prevalence and Incidence of Dementia in Older Veterans with Posttraumatic Stress DisorderSalah U. Qureshi, Timothy A. Kimbrell, Jeffrey M. Pyne, Kathy M. Magruder, Teresa J. Hudson
Journal of the American Geriatrics Society. 2010-09-01 - 165 citationsDetecting frontotemporal dysfunction in ALS: Utility of the ALS Cognitive Behavioral Screen (ALS-CBS™)Susan C. Woolley, Michele K. York, Dan H. Moore, Adriana M. Strutt, Jennifer Murphy
Amyotrophic Lateral Sclerosis. 2010-05-03 - 61 citationsSafety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial.Günter U. Höglinger, Irene Litvan, Nuno Mendonca, Deli Wang, Hui Zheng
The Lancet. Neurology. 2021-03-01
Journal Articles
- Delirious Mania in Bipolar DisorderKimm, TS, Okusaga OO, and Schulz PE, Prim Care Companion CNS Disord, 1/2/2017
- Hippocampal Sclerosis in Older Patients: Practical Examples and Guidance With a Focus on Cerebral Age-Related TDP-43 With SclerosisCykowski MD, Powell SZ, Schulz PE, Takei H, Rivera AL, Jackson RE, Roman G, Jicha GA, and Nelson PT, Arch Pathol Lab Med, 1/1/2017
- NeuropsychiatryArora G, Schulz PE, Neurology Secrets, 1/1/2017
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Deep Brain Stimulation of the Medial Forebrain Bundle: Significant Responses in Treatment Resistant Depression.Fenoy AJ, Schulz P, Selvaraj S, Burrows, Zunta-Soares G, Quevedo J, Soares JC, North American Neuromodulation Society (NANS) 21st Annual Meeting, Las Vegas, NV, 1/11/2018
- Evidence for neuroinflammation in semantic dementia.Pascual MB, Roman GC, Yu M, Pal N, Rockers ED, Fregonara Z, Funk Q, Schulz PE, and Masdeu J, Human Amyloid Imaging Conference, 1/1/2018
- Nonfluent variant of primary progressive aphasia: Tau deposition in the language network.Pascual B, Zanotti-Fregonara P, Funk Q, Rockers E, Pal N, Yu M, Spann B, Schulz P, Masdeu J, American Academy of Neurology (AAN) Meeting, 1/1/2017
- Join now to see all
Lectures
- "Lewy Body Dementia"Austin, TX - 1/25/2017
- "Update on Neuroimaging and Therapeutic Trials in Alzheimer's Disease"Austin, TX - 1/25/2017
- "Recent Advances in Diagnosing and Treating AD"University of Texas Medical Branch, Galveston, TX - 1/22/2017
- Join now to see all
Other
- "Pimavanserin for Parkinson's Disease Psychosis."Schulz PE, Webinar with Fort Worth MDs
1/31/2017 - Commenting on the radio on "It's impossible to ignore this anymore': CTE study details devastating toll on football players."Schulz PE, News Talk 710 KURV
TX - 1/26/2017 - "Alzheimer's Day."Schulz PE, KRUV Radio
1/23/2017 - Join now to see all
Press Mentions
- What to Know About the Alzheimer’s DrugsNovember 6th, 2024
- Researchers Find a Critical Link Between Vaccinations and Alzheimer’s DiseaseOctober 27th, 2024
- First Infusion in Houston for New Alzheimer’s Drug Administered at UTHealth HoustonOctober 7th, 2024
- Join now to see all
Grant Support
- Pilot Study--Amyloid Mediated ToxicityNational Institute On Aging1995–2000
External Links
- All PubMed Publicationshttps://www.ncbi.nlm.nih.gov/myncbi/1d3Rdqa1xETkm7/bibliography/public/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: